Morgan Stanley Anika Therapeutics, Inc. Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 189,178 shares of ANIK stock, worth $3.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

189,178

Previous 452,977 58.24%

Holding current value

$3.29 Million

Previous $11.2 Million 72.18%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$16.04 - $25.53 $4.23 Million - $6.73 Million	-263,799 Reduced 58.24%	189,178 $3.11 Million
Q3 2024 Nov 14, 2024	SELL	$24.25 - $28.75 $1.19 Million - $1.41 Million	-49,011 Reduced 9.76%	452,977 $11.2 Million
Q2 2024 Oct 17, 2024	SELL	$24.57 - $28.47 $4.91 Million - $5.69 Million	-199,744 Reduced 28.46%	501,988 $12.7 Million
Q2 2024 Aug 14, 2024	SELL	$24.57 - $28.47 $4.91 Million - $5.69 Million	-199,744 Reduced 28.46%	501,988 $12.7 Million
Q1 2024 Oct 17, 2024	BUY	$21.95 - $26.42 $4.38 Million - $5.28 Million	199,744 Added 39.79%	701,732 $17.8 Million
Q1 2024 Aug 16, 2024	BUY	$21.95 - $26.42 $4.76 Million - $5.72 Million	216,639 Added 44.66%	701,732 $17.8 Million
Q1 2024 May 15, 2024	BUY	$21.95 - $26.42 $4.76 Million - $5.72 Million	216,639 Added 44.66%	701,732 $17.8 Million
Q4 2023 Aug 16, 2024	SELL	$18.47 - $23.3 $312,050 - $393,653	-16,895 Reduced 3.37%	485,093 $11 Million
Q4 2023 Feb 13, 2024	BUY	$18.47 - $23.3 $4.44 Million - $5.6 Million	240,291 Added 98.16%	485,093 $11 Million
Q3 2023 Nov 15, 2023	SELL	$16.98 - $26.1 $640,655 - $984,753	-37,730 Reduced 13.35%	244,802 $4.56 Million
Q2 2023 Aug 14, 2023	BUY	$25.16 - $28.86 $556,161 - $637,950	22,105 Added 8.49%	282,532 $7.34 Million
Q1 2023 May 15, 2023	BUY	$25.91 - $32.1 $1.76 Million - $2.19 Million	68,088 Added 35.4%	260,427 $7.48 Million
Q4 2022 Feb 14, 2023	SELL	$23.85 - $31.91 $12.4 Million - $16.5 Million	-518,349 Reduced 72.94%	192,339 $5.69 Million
Q3 2022 Nov 14, 2022	BUY	$21.74 - $24.68 $872,339 - $990,309	40,126 Added 5.98%	710,688 $16.9 Million
Q2 2022 Oct 27, 2022	BUY	$20.4 - $25.53 $740,866 - $927,173	36,317 Added 5.73%	670,562 $15 Million
Q2 2022 Aug 15, 2022	BUY	$20.4 - $25.53 $740,866 - $927,173	36,317 Added 5.73%	670,562 $15 Million
Q1 2022 Oct 27, 2022	SELL	$24.7 - $36.54 $897,029 - $1.33 Million	-36,317 Reduced 5.42%	634,245 $15.9 Million
Q1 2022 May 13, 2022	SELL	$24.7 - $36.54 $1.42 Million - $2.1 Million	-57,414 Reduced 8.3%	634,245 $15.9 Million
Q4 2021 Feb 14, 2022	BUY	$35.83 - $45.03 $4.51 Million - $5.67 Million	125,813 Added 22.23%	691,659 $24.8 Million
Q3 2021 Nov 15, 2021	BUY	$38.75 - $44.47 $21.9 Million - $25.2 Million	565,846 New	565,846 $24.1 Million

Others Institutions Holding ANIK

# of Institutions

111

Shares Held

11.1M

Call Options Held

1.8K

Put Options Held

1.9K

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $254M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account